Standardized orthotopic xenografts in zebrafish reveal glioma cell-line-specific characteristics and tumor cell heterogeneity

DMM Disease Models and Mechanisms

Volumn 9, Issue 2, 2016, Pages 199-210

  Welker, Alessandra M ^a   Jaros, Brian D ^a   Puduvalli, Vinay K ^a   Imitola, Jaime ^a   Kaur, Balveen ^a   Beattie, Christine E ^a  

^a THE OHIO STATE UNIVERSITY COLLEGE OF MEDICINE   (United States)

Author keywords

GBM9 neurospheres; Glial fibrillary acidic protein; Glioblastoma; Sox2; Temozolomide; X12 cells

Indexed keywords

ANTINEOPLASTIC AGENT;

ANIMAL; BRAIN NEOPLASMS; GLIOMA; PATHOLOGY; TUMOR CELL LINE; ZEBRA FISH;

ANIMALS; ANTINEOPLASTIC AGENTS; BRAIN NEOPLASMS; CELL LINE, TUMOR; GLIOMA; ZEBRAFISH;

EID: 84957962372     PISSN: 17548403     EISSN: 17548411     Source Type: Journal    
DOI: 10.1242/dmm.022921     Document Type: Article

References (45)

1. Agnihotri, S., Burrell, K. E., Wolf, A., Jalali, S., Hawkins, C., Rutka, J. T. and Zadeh, G. (2013). Glioblastoma, a brief review of history, molecular genetics, animal models and novel therapeutic strategies. Arch. Immunol. Ther. Exp. 61, 25-41.
2. Ananthakrishnan, R. and Ehrlicher, A. (2007). The forces behind cell movement. Int. J. Biol. Sci. 3, 303-317.
3. Chaffer, C. L. andWeinberg, R. A. (2015). How does multistep tumorigenesis really proceed? Cancer Discov. 5, 22-24.
4. Chen, L., Zhang, Y., Yang, J., Hagan, J. P. and Li, M. (2013). Vertebrate animal models of glioma: Understanding the mechanisms and developing new therapies. Biochim. Biophys. Acta 1836, 158-165.
5. Colin, C., Virard, I., Baeza, N., Tchoghandjian, A., Fernandez, C., Bouvier, C., Calisti, A., Tong, S., Durbec, P. and Figarella-Branger, D. (2007). Relevance of combinatorial profiles of intermediate filaments and transcription factors for glioma histogenesis. Neuropathol. Appl. Neurobiol. 33, 431-439.
6. Dinca, E. B., Sarkaria, J. N., Schroeder, M. A., Carlson, B. L., Voicu, R., Gupta, N., Berger, M. S. and James, C. D. (2007). Bioluminescence monitoring of intracranial glioblastoma xenograft: Response to primary and salvage temozolomide therapy. J. Neurosurg. 107, 610-616.
7. Dunn, G. P., Rinne, M. L., Wykosky, J., Genovese, G., Quayle, S. N., Dunn, I. F., Agarwalla, P. K., Chheda, M. G., Campos, B.,Wang, A. et al. (2012). Emerging insights into the molecular and cellular basis of glioblastoma. Genes Dev. 26, 756-784.
8. Eden, C. J., Ju, B., Murugesan, M., Phoenix, T. N., Nimmervoll, B., Tong, Y., Ellison, D. W., Finkelstein, D., Wright, K., Boulos, N. et al. (2014). Orthotopic models of pediatric brain tumors in zebrafish. Oncogene 34, 1736-1742.
9. Galli, R., Binda, E., Orfanelli, U., Cipelletti, B., Gritti, A., De Vitis, S., Fiocco, R., Foroni, C., Dimeco, F. and Vescovi, A. (2004). Isolation and characterization of tumorigenic, stem-like neural precursors from human glioblastoma. Cancer Res. 64, 7011-7021.
10. Geiger, G. A., Fu, W. and Kao, G. D. (2008). Temozolomide-mediated radiosensitization of human glioma cells in a zebrafish embryonic system. Cancer Res. 68, 3396-3404.
11. Giannini, C. (2005). Patient tumor EGFR and PDGFRA gene amplifications retained in an invasive intracranial xenograft model of glioblastoma multiforme. Neuro Oncol. 7, 164-176.
12. Gilbert, C. A. and Ross, A. H. (2009). Cancer stem cells: Cell culture, markers, and targets for new therapies. J. Cell. Biochem. 108, 1031-1038.
13. Godlewski, J., Nowicki, M. O., Bronisz, A., Williams, S., Otsuki, A., Nuovo, G., Raychaudhury, A., Newton, H. B., Chiocca, E. A. and Lawler, S. (2008). Targeting of the Bmi-1 oncogene/stem cell renewal factor by microRNA-128 inhibits glioma proliferation and self-renewal. Cancer Res. 68, 9125-9130.
14. Hu, B., Nandhu, M. S., Sim, H., Agudelo-Garcia, P. A., Saldivar, J. C., Dolan, C. E., Mora, M. E., Nuovo, G. J., Cole, S. E. and Viapiano, M. S. (2012). Fibulin-3 promotes glioma growth and resistance through a novel paracrine regulation of Notch signaling. Cancer Res. 72, 3873-3885.
15. Imitola, J., Raddassi, K., Park, K. I., Mueller, F.-J., Nieto, M., Teng, Y. D., Frenkel, D., Li, J., Sidman, R. L., Walsh, C. A. et al. (2004). Directed migration of neural stem cells to sites of CNS injury by the stromal cell-derived factor 1alpha/CXC chemokine receptor 4 pathway. Proc. Natl. Acad. Sci. USA 101, 18117-18122.
16. Kitambi, S. S., Toledo, E. M., Usoskin, D.,Wee, S., Harisankar, A., Svensson, R., Sigmundsson, K., Kaldere?n, C., Niklasson, M., Kundu, S. et al. (2014). Vulnerability of glioblastoma cells to catastrophic vacuolization and death induced by a small molecule. Cell 157, 313-328.
17. Konantz, M., Balci, T. B., Hartwig, U. F., Dellaire, G., Andre?, M. C., Berman, J. N. and Lengerke, C. (2012). Zebrafish xenografts as a tool for in vivo studies on human cancer. Ann. N. Y. Acad. Sci. 1266, 124-137.
18. Kwiatkowska, A., Didier, S., Fortin, S., Chuang, Y., White, T., Berens, M. E., Rushing, E., Eschbacher, J., Tran, N. L., Chan, A. et al. (2012). The small GTPase RhoG mediates glioblastoma cell invasion. Mol. Cancer 11, 65.
19. Lal, S., La Du, J., Tanguay, R. L. and Greenwood, J. A. (2012). Calpain 2 is required for the invasion of glioblastoma cells in the zebrafish brain microenvironment. J. Neurosci. Res. 90, 769-781.
20. Lally, B. E., Geiger, G. A., Kridel, S., Arcury-Quandt, A. E., Robbins,M. E., Kock, N. D., Wheeler, K., Peddi, P., Georgakilas, A., Kao, G. D. et al. (2007). Identification and biological evaluation of a novel and potent small molecule radiation sensitizer via an unbiased screen of a chemical library. Cancer Res. 67, 8791-8799.
21. Lee, J., Kotliarova, S., Kotliarov, Y., Li, A., Su, Q., Donin, N. M., Pastorino, S., Purow, B.W., Christopher, N., Zhang,W. et al. (2006). Tumor stemcells derived from glioblastomas cultured in bFGF and EGF more closely mirror the phenotype and genotype of primary tumors than do serum-cultured cell lines. Cancer Cell 9, 391-403.
22. Massalini, S., Pellegatta, S., Pisati, F., Finocchiaro, G., Farace, M. G. and Ciafre, S. A. (2009). Reelin affects chain-migration and differentiation of neural precursor cells. Mol. Cell. Neurosci. 42, 341-349.
23. Molina, E. S., Pillat, M. M., Moura-Neto, V., Lah, T. V. and Ulrich, H. (2014). Glioblastoma stem-like cells: Approaches for isolation and characterization. J. Cancer Stem Cell Res. 2, e1007.
24. Mushtaq, M. Y., Verpoorte, R. and Kim, H. K. (2013). Zebrafish as a model for systems biology. Biotechnol. Genet. Eng. 29, 187-205.
25. O'Rourke, N. A. (1996). Neuronal chain gangs: Homotypic contacts support migration into the olfactory bulb. Neuron 16, 1061-1064.
26. Ostrom, Q. T., Gittleman, H., Liao, P., Rouse, C., Chen, Y., Dowling, J., Wolinsky, Y., Kruchko, C. and Barnholtz-Sloan, J. (2014). CBTRUS statistical report: Primary brain and central nervous system tumors diagnosed in the United States in 2007-2011. Neuro. Oncol. 16 Suppl. 4, iv1-iv63.
27. Peal, D. S., Peterson, R. T. and Milan, D. (2010). Small molecule screening in zebrafish. J. Cardiovasc. Transl. Res. 3, 454-460.
28. Phillips, H. S., Kharbanda, S., Chen, R., Forrest,W. F., Soriano, R. H., Wu, T. D., Misra, A., Nigro, J. M., Colman, H., Soroceanu, L. et al. (2006). Molecular subclasses of high-grade glioma predict prognosis, delineate a pattern of disease progression, and resemble stages in neurogenesis. Cancer Cell 9, 157-173.
29. Popova, S. N., Bergqvist, M., Dimberg, A., Edqvist, P.-H., Ekman, S., Hesselager, G., Ponten, F., Smits, A., Sooman, L. and Alafuzoff, I. (2014). Subtyping of gliomas of various WHO grades by the application of immunohistochemistry. Histopathology 64, 365-379.
30. Qiang, L., Yang, Y., Ma, Y.-J., Chen, F.-H., Zhang, L.-B., Liu, W., Qi, Q., Lu, N., Tao, L., Wang, X.-T. et al. (2009). Isolation and characterization of cancer stem like cells in human glioblastoma cell lines. Cancer Lett. 279, 13-21.
31. Rampazzo, E., Persano, L., Pistollato, F., Moro, E., Frasson, C., Porazzi, P., Della Puppa, A., Bresolin, S., Battilana, G., Indraccolo, S. et al. (2013). Wnt activation promotes neuronal differentiation of glioblastoma. Cell Death Dis. 4, e500.
32. Rauta, P. R., Nayak, B. and Das, S. (2012). Immune system and immune responses in fish and their role in comparative immunity study: A model for higher organisms. Immunol. Lett. 148, 23-33.
33. Schindelin, J., Arganda-Carreras, I., Frise, E., Kaynig, V., Longair, M., Pietzsch, T., Preibisch, S., Rueden, C., Saalfeld, S., Schmid, B. et al. (2012). Fiji: An open-source platform for biological-image analysis. Nat. Methods 9, 676-682.
34. Styczynski, J., Olszewska-Slonina, D., Kolodziej, B., Napieraj, M. and Wysocki, M. (2006). Activity of bortezomib in glioblastoma. Anticancer Res. 26, 4499-4503.
35. Suva, M. L., Rheinbay, E., Gillespie, S. M., Patel, A. P., Wakimoto, H., Rabkin, S. D., Riggi, N., Chi, A. S., Cahill, D. P., Nahed, B. V. et al. (2014). Reconstructing and reprogramming the tumor-propagating potential of glioblastoma stem-like cells. Cell 157, 580-594.
36. Taylor, A. M. and Zon, L. I. (2009). Zebrafish tumor assays: The state of transplantation. Zebrafish 6, 339-346.
37. Veinotte, C. J., Dellaire, G. and Berman, J. N. (2014). Hooking the big one: The potential of zebrafish xenotransplantation to reform cancer drug screening in the genomic era. Dis. Model. Mech. 7, 745-754.
38. Vittori, M., Motaln, H. and Turnsek, T. L. (2015). The study of glioma by xenotransplantation in zebrafish early life stages. J. Histochem. Cytochem. 63, 749-761.
39. Wesolowski, J. R., Rajdev, P. and Mukherji, S. K. (2010). Temozolomide (Temodar). Am. J. Neuroradiol. 31, 1383-1384.
40. White, R. M., Sessa, A., Burke, C., Bowman, T., LeBlanc, J., Ceol, C., Bourque, C., Dovey, M., Goessling, W., Burns, C. E. et al. (2008). Transparent adult zebrafish as a tool for in vivo transplantation analysis. Cell Stem Cell 2, 183-189.
41. White, R., Rose, K. and Zon, L. (2013). Zebrafish cancer: The state of the art and the path forward. Nat. Rev. Cancer 13, 624-636.
42. Williams, S. P., Nowicki, M. O., Liu, F., Press, R., Godlewski, J., Abdel-Rasoul, M., Kaur, B., Fernandez, S. A., Chiocca, E. A. and Lawler, S. E. (2011). Indirubins decrease glioma invasion by blocking migratory phenotypes in both the tumor and stromal endothelial cell compartments. Cancer Res. 71, 5374-5380.
43. Wojton, J., Meisen,W. H., Jacob, N. K., Thorne, A. H., Hardcastle, J., Denton, N., Chu, Z., Dmitrieva, N., Marsh, R., Van Meir, E. G. et al. (2014). SapC-DOPSinduced lysosomal cell death synergizes with TMZ in glioblastoma. Oncotarget 5, 9703-9709.
44. Yang, X.-J., Cui, W., Gu, A., Xu, C., Yu, S.-C., Li, T.-T., Cui, Y.-H., Zhang, X. and Bian, X.-W. (2013). A novel zebrafish xenotransplantation model for study of glioma stem cell invasion. PLoS ONE 8, e61801.
45. Zhao, H., Tang, C., Cui, K., Ang, B.-T. and Wong, S. T. C. (2009). A screening platform for glioma growth and invasion using bioluminescence imaging. Laboratory investigation. J. Neurosurg. 111, 238-246.